Monday, March 10th, 2025

Qatar Airways launches new commercial policy


11 March 2020  

Time taken to read : 2 Minute


  • A
  • A
  • A

KATHMANDU: Qatar Airways has launched a new commercial policy aimed at providing customers with maximum flexibility to suit their travel plans.

According to the policy, passengers who have already booked or will book flights for travel up to 30 June 2020 will be offered the flexibility to change their travel plans free of charge.

Passengers can alter the dates of their booking or exchanging their tickets for a travel voucher valid for one year.

The Airways said both changes apply up to three days prior to departure.

This has been designed to provide Qatar Airways’ passengers with confidence and peace of mind when booking flights in light of COVID-19 and its impact on global travel.

Qatar Airways Group Chief Executive, Akbar Al Bakar informed that the safety, security and good health of the passengers and employees have been the Airways’ highest priority.

“Although we maintain the very highest standards of hygiene across all parts of the business, we recognize that some passengers may wish to alter their existing travel plans. We hope this new policy, alongside our robust hygiene practices and safety record, will allow our passengers to travel with confidence,” he said.

Publish Date : 11 March 2020 15:19 PM

Department of Drug Administration approves registration of 25 new medicines

KATHMANDU: The Department of Drug Administration has approved the registration

Inflation lower than last year, foreign exchange reserves sufficient for 14 months of imports

KATHMANDU: Nepal’s external economic indicators remain stable, according to the

Eight local governments in Banke collaborate for disaster risk reduction

NEPALGUNJ: Eight local governments in Banke district have come together

TU Cricket Ground makeover gathers pace

KATHMANDU: The construction of infrastructure at the Tribhuvan University cricket

Department of Drug Administration bans sale of six antibiotics

KATHMANDU: The Department of Drug Administration has announced a ban